A Study of Ixazomib (NINLARO®) in Combination With Lenalidomide and Dexamethasone (IRD) for the Treatment of Participants With Multiple Myeloma (MM)

NCT03173092 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

141

Enrollment

INDUSTRY

Sponsor class

Stopped All participants on the study have concluded treatment, core study activities are complete, and the scientific goals of the study have been met.

Conditions

Multiple Myeloma

Interventions

DRUG: Ixazomib
DRUG: Lenalidomide
DRUG: Dexamethasone

Sponsor

Takeda